Neuronetics
$1.2300
44
+$0.02+1.65% Thursday 20:00
Statistics
Day High
1.298
Day Low
1.2
52W High
4.85
52W Low
0.8
Volume
1,650,500
Avg. Volume
-
Mkt Cap
84.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
4AugExpected
Expected EPS
-0.1245
Actual EPS
N/A
Financials
-58.36%Profit Margin
Unprofitable149.78MRevenue
-87.42MNet Income
Analyst Ratings
3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow STIM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Minerva Neurosciences
NERV
Mkt Cap210.12M
LivaNova
LIVN
Mkt Cap4.36B
Masimo
MASI
Mkt Cap9.42B
Medtronic
MDT
Mkt Cap102.97B
About
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Show more...
CEO
Mr. Daniel L. Reuvers
Employees
716
Country
United States
ISIN
US64131A1051
Listings
0 Comments
Share your thoughts
FAQ
What is Neuronetics stock price today?▼
The current price of STIM is $1.23 USD — it has increased by +1.65% in the past 24 hours. Watch Neuronetics stock price performance more closely on the chart.
What is Neuronetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuronetics stocks are traded under the ticker STIM.
Is Neuronetics stock price growing?▼
STIM stock has fallen by -7.52% compared to the previous week, the month change is a +3.36% rise, over the last year Neuronetics has showed a -64.45% decrease.
What is Neuronetics market cap?▼
Today Neuronetics has the market capitalization of 84.24M
When is the next Neuronetics earnings date?▼
Neuronetics is going to release the next earnings report on August 04, 2026.
What were Neuronetics earnings last quarter?▼
STIM earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.17 USD resulting in a +8.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neuronetics revenue for the last year?▼
Neuronetics revenue for the last year amounts to 149.78M USD.
What is Neuronetics net income for the last year?▼
STIM net income for the last year is -87.42M USD.
How many employees does Neuronetics have?▼
As of June 20, 2026, the company has 716 employees.
In which sector is Neuronetics located?▼
Neuronetics operates in the Health & Wellness sector.
When did Neuronetics complete a stock split?▼
Neuronetics has not had any recent stock splits.
Where is Neuronetics headquartered?▼
Neuronetics is headquartered in Malvern, United States.